PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER
The aim of this article is to present modern approaches to venous thromboembolism prevention in patients with cancer. The paper summarizes international and local experience which is presented in many consensus documents recently issued by professional societies. Any surgery which is performed for oncological patient means extremely high risk of deep vein thrombosis and pulmonary embolism. That is why the prophilaxis is nesessary and mandatory for cancer patients. The basic principle of the prophilaxis is to use anticoagulants, preferrably low molecular weight heparins, in appropriate dosages and for appropriate duration.